Syncor Sells Its Berkeley Diagnostics Subsidiary
Syncor International said it sold its California Integrated Diagnostics subsidiary in Berkeley to The InFerGene Co. for stock worth about $630,000.
Under the agreement, Syncor, a Chatsworth-based nuclear pharmacy supplier, will receive 350,000 shares of common stock in InFerGene, a Benicia, Calif.-based biotechnology company. California Integrated sells diagnostic kits for sexually transmitted diseases such as chlamydia.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
